139 related articles for article (PubMed ID: 6489392)
1. Plasma haloperidol levels and therapeutic response in acute mania and schizophrenia.
Balant-Gorgia AE; Eisele R; Balant L; Garrone G
Eur Arch Psychiatry Neurol Sci; 1984; 234(1):1-4. PubMed ID: 6489392
[TBL] [Abstract][Full Text] [Related]
2. Haloperidol blood levels and effects in schizophrenia and schizoaffective disorder: a progress report.
Volavka J; Cooper TB; Meisner M; Bitter I; Czobor P; Jaeger J
Psychopharmacol Bull; 1990; 26(1):13-7. PubMed ID: 2371368
[TBL] [Abstract][Full Text] [Related]
3. Haloperidol. Plasma levels and prolactin response as predictors of clinical improvement in schizophrenia: chemical v radioreceptor plasma level assays.
Smith RC; Baumgartner R; Misra CH; Mauldin M; Shvartsburd A; Ho BT; DeJohn C
Arch Gen Psychiatry; 1984 Nov; 41(11):1044-9. PubMed ID: 6497566
[TBL] [Abstract][Full Text] [Related]
4. Relationship of serum haloperidol levels to clinical response in schizophrenic patients.
Magliozzi JR; Hollister LE; Arnold KV; Earle GM
Am J Psychiatry; 1981 Mar; 138(3):365-7. PubMed ID: 7468835
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of combination of risperidone and haloperidol with divalproate in patients with acute mania.
Ouyang WC; Hsu MC; Yeh IN; Kuo CC
Int J Psychiatry Clin Pract; 2012 Sep; 16(3):178-88. PubMed ID: 22404731
[TBL] [Abstract][Full Text] [Related]
6. Carbamazepine and haloperidol v placebo and haloperidol in excited psychoses. A controlled study.
Klein E; Bental E; Lerer B; Belmaker RH
Arch Gen Psychiatry; 1984 Feb; 41(2):165-70. PubMed ID: 6365015
[TBL] [Abstract][Full Text] [Related]
7. RBC and plasma levels of haloperidol and clinical response in schizophrenia.
Smith RC; Vroulis G; Shvartsburd A; Allen R; Lewis N; Schoolar JC; Chojnacki M; Johnson R
Am J Psychiatry; 1982 Aug; 139(8):1054-6. PubMed ID: 7091432
[TBL] [Abstract][Full Text] [Related]
8. Plasma haloperidol and reduced haloperidol concentrations in a geriatric population.
Chang WH; Jann MW; Chiang TS; Lin HN; Hu WH; Chien CP
Neuropsychobiology; 1996; 33(1):12-6. PubMed ID: 8821369
[TBL] [Abstract][Full Text] [Related]
9. Haloperidol plasma levels and dose optimization.
Coryell W; Miller DD; Perry PJ
Am J Psychiatry; 1998 Jan; 155(1):48-53. PubMed ID: 9433338
[TBL] [Abstract][Full Text] [Related]
10. Serum level monitoring and therapeutic effect of haloperidol in schizophrenic patients.
Moulin MA; Davy JP; Debruyne D; Andersson JC; Bigot MC; Camsonne R; Poilpré E
Psychopharmacology (Berl); 1982; 76(4):346-50. PubMed ID: 6812109
[TBL] [Abstract][Full Text] [Related]
11. The safety and pharmacokinetics of quetiapine when coadministered with haloperidol, risperidone, or thioridazine.
Potkin SG; Thyrum PT; Alva G; Bera R; Yeh C; Arvanitis LA
J Clin Psychopharmacol; 2002 Apr; 22(2):121-30. PubMed ID: 11910256
[TBL] [Abstract][Full Text] [Related]
12. Total and free plasma neuroleptic levels in schizophrenic patients.
Tang SW; Glaister J; Davidson L; Toth R; Jeffries JJ; Seeman P
Psychiatry Res; 1984 Dec; 13(4):285-93. PubMed ID: 6596586
[TBL] [Abstract][Full Text] [Related]
13. The relationship of haloperidol concentrations to therapeutic response.
Perry PJ; Pfohl BM; Kelly MW
J Clin Psychopharmacol; 1988 Feb; 8(1):38-43. PubMed ID: 3350997
[TBL] [Abstract][Full Text] [Related]
14. Parenteral haloperidol for rapid control of severe, disruptive symptoms of acute schizophrenia.
Reschke RW
Dis Nerv Syst; 1974 Mar; 35(3):112-5. PubMed ID: 17894080
[TBL] [Abstract][Full Text] [Related]
15. Haloperidol decanoate in schizophreniform disorders. Clinical and neuroendocrine aspects.
Meco G; Casacchia M; Attenni M; Iafrate A; Castellana F; Ecari U
Acta Psychiatr Belg; 1983; 83(1):57-68. PubMed ID: 6613612
[TBL] [Abstract][Full Text] [Related]
16. Haloperidol blood levels in acute mania with psychosis.
Chou JC; Czobor P; Dacpano G; Richardson N; Tuma I; Trujillo M; Cooper TB; Volavka J
J Clin Psychopharmacol; 2001 Aug; 21(4):445-7. PubMed ID: 11476130
[TBL] [Abstract][Full Text] [Related]
17. Reduced haloperidol plasma concentration and clinical response in acute exacerbations of schizophrenia.
Kelly MW; Perry PJ; Coryell WH; Miller DD; Arndt SV
Psychopharmacology (Berl); 1990; 102(4):514-20. PubMed ID: 2096408
[TBL] [Abstract][Full Text] [Related]
18. Acutely psychotic patients receiving high-dose haloperidol therapy.
Remington G; Pollock B; Voineskos G; Reed K; Coulter K
J Clin Psychopharmacol; 1993 Feb; 13(1):41-5. PubMed ID: 8486816
[TBL] [Abstract][Full Text] [Related]
19. Plasma/RBC haloperidol ratios and improvement in acute psychotic symptoms.
Neborsky RJ; Janowsky DS; Perel JM; Munson E; Depry D
J Clin Psychiatry; 1984 Jan; 45(1):10-3. PubMed ID: 6363395
[TBL] [Abstract][Full Text] [Related]
20. Haloperidol and lorazepam combined: clinical effects and drug plasma levels in the treatment of acute schizophrenic psychosis.
Stevens A; Stevens I; Mahal A; Gaertner HJ
Pharmacopsychiatry; 1992 Nov; 25(6):273-7. PubMed ID: 1494594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]